Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD109 antibody (AA 22-1258) (PE)

The Mouse Monoclonal anti-CD109 antibody has been validated for FACS. It is suitable to detect CD109 in samples from Human.
Catalog No. ABIN2222108

Quick Overview for CD109 antibody (AA 22-1258) (PE) (ABIN2222108)

Target

See all CD109 Antibodies
CD109

Reactivity

  • 44
  • 13
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 38
  • 9
  • 2
Mouse

Clonality

  • 41
  • 8
Monoclonal

Conjugate

  • 29
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD109 antibody is conjugated to PE

Application

  • 25
  • 21
  • 12
  • 7
  • 7
  • 6
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Clone

12K46
  • Binding Specificity

    • 8
    • 8
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 22-1258

    Cross-Reactivity

    Human

    Cross-Reactivity (Details)

    Calculated cross reactivity: Hu

    Characteristics

    CD109 (CD109 Antigen, 150kD TGF-beta-1-binding Protein, C3 and PZP-like alpha-2-macroglobulin Domain-containing Protein 7, Platelet-specific Gov Antigen, p180, r150, CPAMD7) (PE)

    Purification

    Purified by Protein G affinity chromatography.

    Immunogen

    Recombinant corresponding to aa22-1258 from human CD109 expressed in NSO cell line.

    Isotype

    IgG2a
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as a liquid in saline, 0.5 % BSA, 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    4°C ,Do Not Freeze
  • Target

    CD109

    Alternative Name

    CD109

    UniProt

    Q6YHK3

    Pathways

    Activated T Cell Proliferation
You are here:
Chat with us!